Document:

EX-10.17

 

Exhibit 10.17

EMPLOYMENT CONTINUITY AGREEMENT

     THIS EMPLOYMENT CONTINUITY AGREEMENT (this “Agreement”) is between LSB BANCSHARES, INC., a
North Carolina Corporation (referred to in this Agreement as the “Company,” which term includes any
subsidiary of the Company unless the context clearly indicates otherwise), and ANDREW G. McDOWELL,
an executive of the Company and a resident of North Carolina (the “Executive”), and is effective as
of December 22, 2004 (the “Effective Date”).

     The Company’s Board of Directors (the “Board”) acknowledges that the Executive’s contributions
to the growth and success of the Company will be substantial.

     Outstanding management of the Company is essential to advancing the best interests of the
Company and its shareholders. The Board believes that the objective of securing and retaining the
Executive will be achieved if the Executive is given assurances of employment security so that he
will not be distracted by personal uncertainties and risks.

     The Board believes that such assurances will secure the continued services of the Executive in
the performance of his regular duties and such extra duties as may be required of him during
periods of uncertainty and will enable the Company to rely on such Executive to manage its affairs
with less concern for his personal risks.

     The Stock Option and Compensation Committee of the Board (the “Committee”) has recommended,
and the Board has approved, entering into this Agreement with the Executive in order to achieve the
foregoing objectives.

     1. Term. Upon execution by the Company and the Executive, this Agreement is
effective as of the Effective Date. Unless terminated in accordance with Sections 3(a)(i) or
3(a)(ii) of this Agreement, the term of this Agreement will commence as of the Effective Date and
continue until the first anniversary of the Effective Date, and the term of this Agreement shall
automatically be extended an additional one day whenever the term of the Agreement has less than
one year remaining, so that the term of the Agreement shall always have at least one year
remaining, unless terminated in accordance with Sections 3(a)(i) or 3(a)(ii) of this Agreement.

     2. Terms of Employment.

     (a) Positions and Duties. The Company agrees to employ the Executive, and the
Executive agrees to serve as an employee of the Company. The Executive shall perform such
duties and responsibilities, in such capacity and with such authority, for the Company as
the Company may designate from time to time. Such duties shall be of a type for which the
Executive is suited by background, experience and training, in the Company’s reasonable
discretion. Excluding any periods of vacation and sick leave to which the Executive is
entitled, the Executive agrees to devote his full professional attention and time during
normal business hours to the business and affairs of the Company and to perform the
responsibilities assigned to the Executive.

     (b) Working Facilities and Support Staff. The Executive is entitled to an
office of a size and with furnishings and other appointments comparable to other executives
in similar positions with the Company. The Executive is entitled to secretarial and other
assistance, and to

1

 

such other facilities, equipment, and supplies comparable to other executives in
similar positions with the Company.

     (c) Expenses Generally. The Executive is entitled to receive prompt
reimbursement for all reasonable expenses incurred by the Executive in accordance with the
Company’s policies and procedures.

     (d) Meetings, Conventions, and Seminars. The Executive is encouraged to attend
seminars, professional meetings and conventions, and educational courses that are reasonably
related to the Executive’s employment with the Company. The cost of travel, tuition or
registration, food, and lodging for attending those activities shall be paid by the Company
in accordance with the Company’s policies and procedures for such reimbursement.

     (e) Promotional Expenses. The Executive is encouraged to incur reasonable
expenses for promoting the Company’s business. Such promotional expenses include travel,
entertainment (including memberships in social and athletic clubs), professional
advancement, and community service expenses. The Executive agrees to bear those expenses
except to the extent that those expenses are incurred at the Company’s specific direction or
those expenses are specifically authorized by the Company as expenses that the Company may
pay directly or indirectly through reimbursement to the Executive.

     (f) Outside Activities. The Executive may (i) serve on corporate, civic, or
charitable boards or committees; (ii) deliver lectures, fulfill speaking engagements, or
teach at educational institutions; and (iii) manage personal investments, provided that such
activities do not materially interfere with the performance of the Executive’s
responsibilities for the Company. To the extent that any such activities have been conducted
by the Executive before the Effective Date, such prior conduct of activities and any
subsequent conduct of activities similar in nature and scope shall not be deemed to
interfere with the performance of the Executive’s responsibilities for the Company.

     (g) Compensation. The Executive shall be entitled to an annual base salary of
no less than $105,000.00, as the same may be adjusted by the Company from time to time
(“Annual Base Salary”). In addition, the Executive shall be entitled to participate in the
various plans and programs (including employee benefit plans) as may be offered by the
Company from time to time, in accordance with the terms and provisions of such plans or
programs.

     3. Termination of Employment. The Executive’s employment with the Company may be
terminated at any time for any or no reason, with or without cause, including any of the following
events listed in Sections 3(a) or 3(b) below:

     (a) Non-Covered Terminations. The following events shall be considered
“Non-Covered Terminations” under this Agreement:

     (i) Termination of Employment on Disability. The Company, pursuant to a
resolution duly adopted by the Board, may terminate the Executive’s employment if
the Executive becomes Disabled by giving the Executive written notice of its
intention to terminate the Executive’s employment, subject to the terms and
conditions specified in the notice. If the Executive becomes Disabled and does not
return to the performance of his duties for the Company in accordance with the terms
and conditions set forth in the notice, the Executive’s employment with the Company
shall terminate. For purposes of

2

 

this Agreement, “Disabled” has the meaning set forth under the Long Term
Disability Plan of Lexington State Bank or any successor plan or amendment to such
Plan.

     (ii) Termination of Employment on Death. If the Executive dies, his
employment shall automatically terminate as of the date of the Executive’s death.

     (iii) Company’s Termination of the Executive for Cause. The Company’s
termination of the Executive’s employment with the Company for Cause. For purposes
of this Agreement “Cause” shall mean any of the following:

     (a) Use of illegal drugs by the Executive;

     (b) Any material breach by the Executive of any covenant, including the
covenant in Section 5(a) of this Agreement, causing material injury to the
Company or to the business reputation of the Company;

     (c) Any willful act or omission of the Executive which is injurious to
the Company or to the business reputation of the Company;

     (d) The dishonesty, fraud, malfeasance, negligence or misconduct of the
Executive;

     (e) The conviction of, or entry of a plea of guilty or no contest to, a
felony or crime involving moral turpitude by the Executive;

     (f) Failure of the Executive to materially comply with the policies of
the Company;

     (g) The continued failure of the Executive to perform substantially the
Executive’s duties with the Company (other than any such failure resulting
from incapacity due to physical or mental illness), after a written demand
for substantial performance is delivered to the Executive by the Company
which specifically identifies the manner in which the Company believes that
the Executive has not substantially performed the Executive’s duties.

     (h) Failure of the Executive to materially follow lawful instructions
of the Board.

     (iv) Voluntary resignation by the Executive without Good Reason, as defined in
subparagraph (b)(ii) of this Section 3.

     (b) Covered Terminations. The following events shall be considered “Covered
Terminations” under this Agreement:

     (i) Company’s Termination of Executive Without Cause and Without an Offer
of Comparable Employment. The Company’s termination of the Executive’s
employment (1) without Cause (as defined in Section 3(a)(iii)) and (2) without an
offer of Comparable Employment with a Successor Employer or a Code §414 Affiliated
Employer of the Company or of a Successor Employer that agrees to assume and be
bound by all terms and conditions of this Agreement and to become the “Company”
under this Agreement.

3

 

     (a) Code §414 Affiliated Employer shall mean an employer whose
employees would be aggregated with the employees of the Company, and treated
as employed by a single employer along with the employees of the Company,
pursuant to Code §414(b) “controlled groups of corporations”), Code 414(c)
(“entities under common control”), or Code 414(m)(5) (management affiliated
service groups).

     (b) Comparable Employment shall mean, with respect to the
Executive and a termination of his employment with the Company, employment
by a Successor Employer or by a Code §414 Affiliated Employer (1) for salary
or wages which are equal to or greater than the salary or wages paid to the
Executive by the Company immediately prior to such termination of employment
of the Executive, (2) which does not require the Executive to relocate more
than twenty-five (25) miles from the Executive’s primary place of employment
as of the Effective Date, and (3) which does not result in a substantial
reduction of the benefits to which the Executive is entitled immediately
prior to such termination of employment of the Executive.

     (c) Successor Employer shall mean any entity that acquires
substantially all of the Company’s assets or any entity into which the
Company was merged or consolidated.

     (ii) Termination By the Executive With Good Reason. The termination of
the Executive’s employment with the Company by the Executive with Good Reason. Good
Reason shall exist if the Company, without the Executive’s consent: (a)
substantially reduces the overall importance of the Executive’s then current role,
as determined by balancing any increase or decrease in the scope of the Executive’s
management responsibilities against any increase or decrease in the relative sizes
of the businesses, activities or functions (or portions thereof) for which the
Executive has responsibility; provided, however, that none of (i) a change in the
Executive’s title, (ii) a change in the hierarchy, (iii) a change in the Executive’s
responsibilities from line to staff or vice versa, and (iv) placing the Executive on
temporary leave pending an inquiry into whether the Executive has engaged in conduct
that could constitute “Cause” under this Agreement, either individually or in the
aggregate, shall be considered Good Reason; (b) reduces the Executive’s Annual Base
Salary, unless a similar reduction is made for other senior executives of the
Company in response to market conditions, (c) substantially reduces the aggregate
benefits (on a cost basis) to which the Executive is entitled on the Effective Date,
unless a similar reduction is made for other executive employees of the Company, (d)
commits a breach of this Agreement which is not remedied by the Company within
thirty (30) days of receiving written notice from the Executive of such breach, (e)
requires the Executive to relocate more than twenty-five (25) miles from the
Executive’s principal place of employment as of the Effective Date, (f) following a
Change in Control, requires the Executive to travel on Company business, without his
consent, at least 50% more, on average, than during the 12 months immediately
preceding the Change in Control, or (g) any successor or assignee of the Company
fails to assume and perform the Company’s obligations under this Agreement.
Executive will be entitled to receive Severance Payments under Section 4(b)(i) of
this Agreement on account of his voluntary termination under this Section 3(b)(ii)
only if such voluntary termination with Good Reason occurs within six months after
an event described in this Section 3(b)(ii), or within six months after the last in
a series of such events.

4

 

     (iii) Termination by the Executive Following a Change in Control. The
termination of the Executive’s employment with the Company by the Executive if the
Company or the Board, without the Executive’s written consent, violates or takes
direct action or inaction that would violate the Company’s code of ethics as in
effect immediately prior to the Change in Control.

     (c) Other Terminations. Any termination of the Executive’s employment with the
Company that is not listed in Sections 3(a) or 3(b) above shall be deemed to be a
Non-Covered Termination under Section 3(a) above.

     (d) Change in Control. For purposes of this Agreement, a “Change in Control”
occurs if, after the Effective Date, (i) either (A) any Person (other than a trustee or
other fiduciary holding securities under an employee benefit plan of the Company or the
Company itself) becomes the owner or beneficial owner of Company securities having 20% or
more of the combined voting power of the then outstanding Company securities that may be
cast for the election of the Board (other than as a result of an issuance of securities
initiated by the Company, or open market purchases approved by the Board, as long as the
majority of the Board approving the purchases are directors at the time the purchases are
made); or (B) a cash tender or exchange offer for 20% or more of the combined voting power
of the then outstanding Company securities that may be cast for the election of the Board is
effected, a merger, consolidation, reorganization or other business combination involving
the Company occurs, a sale of all or substantially all of the Company’s assets occurs, a
contested election of directors occurs, or any combination of these transactions or similar
events occur, and (ii) at any time, the Continuing Directors (as defined below) cease to
constitute a majority of the Board or any successor’s board for whatever reason.

     For purposes of the preceding paragraph, “Continuing Director” means any member of the
Board while a member of the Board, and who (i) was a director of the Company before the
consummation of the transactions described in the preceding sentence or (ii) whose
subsequent nomination for election or election to the Board was recommended or approved by a
majority of the Continuing Directors then serving on the Board with each such member then
being treated as a director in (i); and “Person” means any individual, firm, corporation,
partnership, limited liability company, trust or other entity, including a “group” as
defined in Section 13(d)(3) of the Securities Exchange Act of 1934, and any successor (by
merger or otherwise) of such entity.

     4. Post-Termination Payment Obligations of the Company.

     (a) Non-Covered Terminations. If the Executive’s employment with the Company
terminates by reason of a Non-Covered Termination under Section 3(a), then no further
remuneration shall be paid to the Executive pursuant to this Agreement after such
termination of employment, and the Executive shall only be entitled to remuneration
thereafter pursuant to the terms and conditions of his employment with the Company which has
accrued but not been paid.

     (b) Covered Terminations. If the Executive’s employment with the Company
terminates by reason of a Covered Termination under Section 3(b), then, in addition to any
accrued remuneration to which the Executive may otherwise be entitled pursuant to the terms
and conditions of his employment with the Company, the Executive shall receive the following
additional remuneration from the Company:

     (i) Severance Payments. The Company shall pay to the Executive an
amount on the first day of each month during the Severance Period equal to
one-twelfth (1/12) of the Annual Base Salary. Additionally, the Company shall pay
to the Executive

5

 

an amount on the first day of each month during the Severance Period equal to
one-twelfth (1/12) of any bonuses or other taxable cash compensation other than the
Annual Base Salary which was awarded to the Executive during the calendar year
preceding the calendar year in which occurs the date of the Executive’s termination
of employment with the Company. For purposes of this Agreement, the term “Severance
Period” means a one- (1) year period beginning on the date on which the Executive’s
employment with the Company terminated, unless the Executive’s employment with the
Company terminates within six (6) months after a Change in Control has occurred, in
which case the term “Severance Period” means a two- (2) year period beginning on the
date on which the Executive’s employment with the Company terminated. The Company’s
obligation to make and the Executive’s right to receive the payments described in
Section 4(b) (the “Severance Payments”) shall cease immediately in the event that
the Executive violates the Covenant Not to Compete contained in Section 5(c)(i).

     (ii) Payment of COBRA Premiums. During the Executive’s Severance
Period, the Company shall reimburse the Executive for the premiums required to be
paid under the Company’s group health plans to provide the Executive and all
dependents of the Executive with the continuation coverage available under Code
§4980B and ERISA §§601-608. Such reimbursements shall be provided to the Executive
promptly following the date of submission of such expenses to the Company.
Notwithstanding the foregoing, no provisions of this subsection (b) shall be
interpreted, or are intended to, change the terms and provisions of any group health
plan of the Company. Reimbursements under this subsection (b) shall only be made to
the extent that the Executive and/or his eligible dependents have obtained
continuation coverage under the terms and provisions of the group health plans of
the Company, and the ability of the Executive and/or his eligible dependents to
obtain such coverage shall be governed exclusively by the terms and provisions of
the group health plans themselves.

     (c) Withholding on Payments. All payments made or services provided to the
Executive under this Agreement shall be subject to applicable withholdings, including
federal and state income or other taxes and Social Security taxes.

     (d) Other Remuneration from Company. As of the date of termination of the
Executive’s employment with the Company, the Executive’s rights to any particular employee
benefit will be governed by applicable law and the terms and provisions of the Company’s
various employee benefit plans and arrangements. The date of termination of the Executive’s
employment with the Company shall be used in determining benefits under all Company employee
benefit plans.

     (e) Payment Limitation. If the amounts to be paid to the Executive under this
Agreement would cause the Executive to be subject to the Code §4999 excise tax, then to the
extent that the total “parachute payments” (as defined in Code §280G(b)(2) are equal to or
greater than three (3) times the Executive’s “base amount” (as defined in Code §280G(b)(3)),
the amounts to be paid to the Executive under this Agreement which would constitute
“parachute payments” shall be reduced to the extent necessary so that the total “parachute
payments” shall be $1.00 less than three (3) times the Executive’s “base amount”; but the
amounts to be paid shall be so reduced only if the Executive would be economically better
off, on an after tax (federal and state income and federal excise) basis, receiving less
under this Agreement because of the Code §4999 excise tax that would otherwise apply to the
higher amount otherwise payable under this Agreement. The Company shall have complete
discretion to appoint competent tax experts to make the calculations required by this
Section, and the calculations made by such experts shall be

6

 

final and binding upon both the Company and the Executive. Any reductions required
under this Section shall come first from the payments required under Section 4(b)(i), and
then from other payments required under Section 4(b) in the sole discretion of the Company.

     (f) FDIC Compliance Limitation. If the amounts to be paid to the Executive
under this Agreement would cause the Executive to receive a payment in violation of 12 CFR
§359 (or the corresponding provisions of any future regulations promulgated under Section
18(k) of the Federal Deposit Insurance Act (12 U.S.C. §1828(k)), then, after seeking the
approval of the FDIC to nonetheless make payment of such amounts, if such approval is not
forthcoming, such amounts shall be limited so that no violation of such regulations will
occur.

     (g) Waiver and Release. The Company’s obligation to pay amounts to be paid
under Section 4(b) of this Agreement shall be contingent upon the Executive executing and
not revoking a Waiver and Release in the form attached to this Agreement as Exhibit A.

     5. Executive Covenants.

     (a) Confidential Information. The Executive shall hold in a fiduciary capacity
for the benefit of the Company all secret or confidential information, knowledge, or data
relating to the Company and its business, which is obtained by the Executive during the
Executive’s employment by the Company and which is not public knowledge (other than by acts
by the Executive or his representatives in violation of this Agreement). During and after
the termination of the Executive’s employment with the Company, the Executive shall not,
without the Company’s prior written consent, communicate or divulge any such information,
knowledge, or data to anyone other than the Company and those designated by it to receive
such information, knowledge, or data except pursuant to an order of a court or governmental
agency. If the Executive violates this Section 5(a), any unpaid remuneration under Section
4(b) shall immediately be forfeited as of the date of the violation.

     (b) Records and Files. All records and files concerning the Company or the
Company’s customers belong to and shall remain the property of the Company. In the event
that the Executive’s employment is terminated for any reason, he shall immediately return to
the Company all such records and files, including copies and files and records stored on
disks or in other electronic format.

     (c) Covenant Not to Compete.

     (i) The Executive agrees that if his employment terminates for any reason other
than when he becomes Disabled or dies, then during the Severance Period (defined in
Section 4(b)(i)) and within Forsyth County, North Carolina, all counties contiguous
to Forsyth County, North Carolina, and all counties in which the Company has a
banking office on the date of termination of the Executive’s employment, he shall
not serve as an employee of, or become a director of, or render advisory or other
services for, or in connection with, or make any financial investment in excess of
5% of the outstanding capital stock of, a bank or other financial institution that
provides services or products that are the same as, similar to, or otherwise
competitive with the services or products provided by the Company. The Executive
further agrees that during the Severance Period (defined in Section 4(b)(i)), he
shall not actively induce any Company employee to terminate employment with the
Company in favor of promised or prospective employment with or on behalf of the
Executive or the Executive’s post-termination employer. The Company’s obligation to
make the Executive’s right to receive payments

7

 

described in Section 4(b) (the “Severance Payments”) shall cease immediately in
the event that the Executive violates the Covenant Not to Compete contained in
Section 5(c)(i).

     (ii) The Executive agrees and acknowledges that any breach of the covenants
contained in this Section 5(c) shall cause irreparable injury to the Company, and
that the remedy at law for any such breach shall be inadequate, and that the Company
shall be entitled to appropriate equitable relief, including injunctive relief, in
addition to any other available remedies.

     (iii) The covenants contained in this Section 5(c) shall inure to the benefit
of the Company and its affiliated employers and subsidiaries and their successors.

     (iv) The restrictions contained in this Section 5(c) are considered by the
parties hereto to be fair and reasonable and necessary for the protection of the
legitimate business interests of the Company. If the scope of any restriction
contained in this Section 5(c) is determined by a court of competent jurisdiction to
be too broad to permit enforcement of such restriction to its full extent, then such
restriction shall be enforced to the maximum extent permitted by law, and the
Executive hereby consents and agrees to such scope as may be judicially modified.

     (v) Notwithstanding Section 4(b), if the Executive violates this Section 5(c),
any unpaid remuneration under Section 4(b) shall immediately be forfeited as of the
date of any violation.

     (vi) The Executive agrees that the time period of the covenants in this Section
5(c) shall not be reduced, but shall be extended, by any period of time during which
the Executive is in violation of any such covenant or any period of time required
for litigation by the Company to enforce any such covenant.

     6. Legal Fees and Expenses. The Company shall pay all reasonable legal fees and
expenses, if any, incurred by the Executive in successfully obtaining, enforcing, or defending any
right or benefit provided by this Agreement. Payments under this Section are in addition to the
remuneration provided by other sections of this Agreement.

     7. Governing Law. This Agreement and performance hereunder and all suits, actions and
other proceedings hereunder shall be construed in accordance with and under and pursuant to the
laws of the State of North Carolina (except its choice of law provisions to the extent that they
would require the application of the laws of a state other than the State of North Carolina), and
in any suit, action or other proceeding that may be brought arising out of, in connection with, or
by reason of this Agreement, the laws of the State of North Carolina (except its choice of law
provisions to the extent that they would require the application of the laws of a state other than
the State of North Carolina) shall be applicable and shall govern to the exclusion of the law of
any other forum, without regard to the jurisdiction in which any suit, action or other proceeding
may be instituted.

     8. Amendment. This Agreement may not be amended except by the written agreement of the
Executive and the Company (with the Company acting by adoption of a resolution by the Board
recommended by the Committee).

     9. Binding Effect. The parties agree that this Agreement is enforceable under the laws
of the State of North Carolina. This Agreement is binding on the Company, its successors, and
assigns and on

8

 

the Executive and his personal representatives; and the Company will not consolidate or merge
into or with another corporation, or transfer all or substantially all of its assets to another
entity (the “Successor”) unless the Successor entity shall assume this Agreement, and upon such
assumption, the Executive and the Successor shall become obligated to perform the terms and
conditions of this Agreement. This Agreement inures to the benefit of and is enforceable by the
Executive’s personal or legal representatives, executors, administrators, successors, heirs,
distributees, devisees, and legatees. If the Executive dies while any amounts are payable under
this Agreement, all such amounts, unless otherwise provided, shall be paid in accordance with the
terms of this Agreement to the Executive’s spouse, or if none, to his devisee, legatee, or other
designee or, if there be no such designee, to his estate.

     10. Notice. For purposes of this Agreement, notices and all other communications shall
be in writing (except notice of termination of employment by the Company without cause or for
cause, which may be oral and shall be effective when given orally, but which shall be confirmed in
writing to the Executive within five business days thereafter, and except for notice of a voluntary
termination of employment by the Executive, which may be oral and shall be effective when given
orally, but which shall be confirmed in writing to the Company within five business days
thereafter) and are effective when delivered or mailed by United States registered mail, return
receipt requested, postage prepaid, addressed to the Executive or his personal representative at
his last known address or when hand delivered to the Executive’s last known address. All notices
to the Company shall be directed to the attention of the Chairman of the Board. Such other
addresses may be used as either party may have furnished to the other in writing. Notices of change
of address are effective only upon receipt.

     11. Miscellaneous. This Agreement contains all of the understandings and
representations between the parties hereto pertaining to the subject matter hereof and supersedes
all undertakings and agreements, whether oral or in writing, if any, previously entered into by
them with respect thereto. Headings contained herein are for convenience reference only and shall
not in any way affect the meaning or interpretation of this Agreement. All payments under this
Agreement shall be subject to applicable income, excise and employment tax withholding
requirements. No provision of this Agreement may be modified, waived, or discharged unless such
waiver, modification, or discharge is agreed to in writing signed by the Executive and the Company.
A waiver of any breach of or compliance with any provision or condition of this Agreement is not a
waiver of similar or dissimilar provisions or conditions. The invalidity or unenforceability of any
provision of this Agreement does not affect the validity or enforceability of any other provision
of this Agreement, which remains in full force and effect.

     12. No Assignment. The Executive may not assign, alienate, anticipate, or otherwise
encumber any rights, duties, or amounts that he might be entitled to receive under this Agreement.

     13. No Strict Construction. If there is a dispute about the language of this
Agreement, the fact that one party drafted this Agreement shall not be used in its interpretation
or enforcement.

     14. Affirmation. The Executive acknowledges that he has carefully read this
Agreement, that he knows and understands its terms and conditions, and that he has had the
opportunity to ask the Company any questions he might have had prior to signing this Agreement.
The Executive also acknowledges that he has had the opportunity to consult an attorney of his
choice (at his expense) to review this Agreement before signing it.

     15. Covenants. The covenants contained in this Agreement shall survive cessation of
the Executive’s employment with the Company as set forth in this Agreement, regardless of who
causes the cessation or the reason for the cessation.

9

 

     16. Non-Binding Mediation Required Prior to Litigation. The parties agree that in the
event that any disagreement arises under this Agreement concerning any payment of remuneration to
be made under this Agreement, or the interpretation or application of this Agreement, or any of the
provisions of this Agreement, or any other matter with respect to the employment of the Executive
by the Company pursuant to this Agreement, other than matters covered by Section 5 of this
Agreement, then prior to the institution of any litigation by either party, such disagreement shall
be first mediated by the parties who will use one mediator agreeable to them (or who is selected by
two mediators each agreeable to one of the parties hereto if the parties are unable to agree
unanimously on one mediator). Notwithstanding the foregoing, the parties agree that such
non-binding mediation shall not be required prior to the institution of litigation by the Company
to obtain injunctive or other equitable relief to enforce any of the covenants in Section 5 of this
Agreement. Any such mediation shall not be binding upon either party, and the cost of any such
mediation proceedings, other than the Executive’s legal fees and expenses, the payment of which
shall be governed by the provisions of Section 6 of this Agreement, shall be borne exclusively by
the Company.

The parties have executed this Agreement effective as of the 22nd day of December,
2004.

	 	 	 	 	 
	 	LSB BANCSHARES, INC.

 	 
	 	/s/ Robert F. Lowe
 	 
	 	
	 
	 	By: Robert F. Lowe 	 
	 	Its: Chairman, President and Chief Executive Officer

ANDREW G. McDOWELL

/s/ Andrew G. McDowell	 
	 	
	 

10

 

	 	 	 	 	 

EXHIBIT A

WAIVER AND RELEASE AGREEMENT

This Waiver and Release Agreement reflects the promises, releases, understanding and agreement made
by ANDREW G. McDOWELL (“Executive”) regarding the termination of Executive’s employment with LSB
BANCSHARES, INC. (the “Company”).

I. Payment to Executive

Following the eighth day after the execution of this Release by Executive, the Company agrees to
pay to Executive the Severance Payments and reimburse Executive for COBRA premiums as provided
under Section 4 of that certain Employment Continuity Agreement between Executive and the Company
effective as of December 22, 2004, less all required payroll tax withholdings.

Executive agrees and acknowledges that these payments constitute consideration in addition to
anything of value to which he or she would otherwise have been entitled absent the execution of
this Agreement. Other than the payment of said amounts and any benefits due to Executive under
existing retirement and fringe benefits plans in which Executive is a participant, in accordance
with the terms of such plans, Executive shall not be entitled to any other payments or benefits
from the Company.

II. Release and Waiver

For the consideration described herein, Executive hereby releases, waives, and forever discharges
the Company and all of their benefit plans, plan administrators, agents, subsidiaries, affiliates,
employees, officers, shareholders, successors, and assigns (hereafter “the Releasees”) from any and
all liability, actions, charges, causes of action, demands, damages, attorneys’ fees, or claims for
relief or remuneration of any kind whatsoever, whether known or unknown at this time, arising out
of or in any way connected with Executive’s employment or the termination of his or her employment
with the Company. These include, but are not limited to, any claim (including related attorneys’
fees and costs) under the Age Discrimination in Employment Act, Title VII of the Civil Rights Act
of 1964, the Americans with Disabilities Act, the Worker’s Adjustment and Retraining Notification
Act, the Equal Pay Act, the Post Civil War Civil Rights Act, or any other federal, state, or local
law or ordinance, and any claim for benefits or other claims under the Employee Retirement Income
Security Act, except those which relate to the payment of 401(k) benefits if any, which Executive
is entitled to receive. This waiver, release and discharge also includes without limitation, any
wrongful or unlawful discharge claims, discipline or retaliation claims, any claims relating to any
contract of employment, whether express or implied, any claims related to promotions or demotions,
any claims for or relating to relocation, compensation including commissions, short term or long
term incentives, the 401(k) plan and the management thereof, any claims for defamation, slander,
libel, invasion of privacy, misrepresentation, fraud, infliction of emotional distress, any claims
based on stress to the extent permitted by law, any claims for breach of any covenant of good faith
and fair dealing, and any other claims relating to Executive’s employment with the Company and
termination thereof.

This Waiver and Release Agreement (“Agreement”) does not apply to any claims or rights that may
arise under the Age Discrimination in Employment Act after the date that this Agreement is
signed.

Executive expressly waives all claims, including those which he or she does not know or suspect to
exist in her favor as of the date of this Agreement. As used herein, the parties understand the
word “claims” to include all actions, claims, and grievances, whether actual or potential, known or
unknown, and specifically but not exclusively including all claims against the Company and the
Releasees arising from

11

 

or relating to Executive’s employment with the Company, the termination thereof or any other
conduct by the Company or the Releasees occurring on or prior to the date Executive signs this
Agreement. All such claims are forever barred by this Agreement whether they arise in contract or
tort or under a statute or any other law.

It is expressly understood and agreed by the parties that this Agreement is in full accord,
satisfaction and discharge of any and all doubtful and/or disputed claims by Executive against the
Releasees, and that this Agreement has been signed with the express intent of extinguishing all
claims, obligations, actions or causes of action as herein described.

III. Voluntary Agreement and Other Acknowledgments

Executive acknowledges that:

	•  	I have read this Waiver and Release Agreement, and I
understand its legal and binding effect. I am knowingly and
voluntarily executing this Waiver and Release Agreement of
my own free will.
	 
	•  	No other promises or agreements of any kind have been made
to or with me by any person or entity to cause me to sign
this Waiver and Release Agreement.
	 
	•  	I have had the opportunity to seek, and the Company has
expressly advised me to seek, legal counsel prior to
signing this Waiver and Release Agreement.
	 
	•  	I have been given at least 45 days from the date I received
this form to consider the severance benefits being offered
to me and the terms of this Waiver and Release Agreement.
	 
	•  	If I am age 40 or more, on the date that I received a copy
of this Waiver and Release Agreement, I also received a
description of:

	 	1)  	The class, unit, or group of individuals whose employment is being terminated
as part of the same employment termination program (if any), the eligibility factors
for this program, and any time limits applicable to the program; and
	 
	 	2)  	The job titles and ages of all individuals covered under the termination
program (if any) and the ages of all individuals in the same job classification or
organizational unit who are not covered.

	•  	I understand that in signing this Waiver and Release Agreement, I
am waiving and releasing all claims I have against the Company and
the Releasees which have arisen up to and including the date I
execute this document, including without limitation, those arising
under the Age Discrimination In Employment Act of 1967, as
amended.
	 
	•  	I have been paid in full all wages, incentives, bonuses and other
compensation owed to me by the Company.

IV. Revocation of Waiver and Release Agreement

I understand that, if I am age 40 or more, I can change my mind and revoke my signature on the
Waiver and Release Agreement within seven days after signing it by hand delivering notice of such
revocation to the President of the Company. I understand that, unless properly revoked by me during
this seven-day

12

 

period, the release and waiver in the first section above will become effective seven days after I
sign the Waiver and Release Agreement.

V. Non-Disparagement.

Executive represents and agrees that he or she has not, and will not, except to the extent required
by law, disparage or defame any person associated with the Company, or any programs or services
offered by or through the Company.

VI. Complete Agreement.

Executive acknowledges that no representation, promise or inducement has been made other than as
set forth in this Agreement, and that he or she does not enter into this Agreement in reliance upon
any representation, promise or inducement not set forth herein. This Agreement supersedes all prior
negotiations and understandings of any kind with respect to the subject matter and contains all of
the terms and provisions of the agreement between Executive and the Company with respect to the
subject matter hereof. Any representation, promise or condition, whether written or oral, not
specifically incorporated herein, shall be of no binding effect.

VII. Governing Law

This Agreement shall be governed by the Employee Retirement Income Security Act and, where
applicable, the law of the State of North Carolina.

	 	 	 	 	 
	 

	 	 	 	 
	ANDREW G. McDOWELL

	 	 	 	Date

o I have voluntarily elected to accept the benefits described herein and execute this Waiver
and Release Agreement prior to the end of the 45-day period offered to me, and I have made this
decision without coercion.

13Amendment No. 2 to Credit Agreement

 

Exhibit 10.10

AMENDMENT NO. 2 TO CREDIT AGREEMENT

     This Amendment No. 2 to Credit Agreement (this “Agreement”) dated as of March 10, 2005 is made
by and among PEDIATRIX MEDICAL GROUP, INC., a Florida corporation, and certain of its subsidiaries
and affiliates (collectively, the “Borrowers”), BANK OF AMERICA, N.A., a national banking
association organized and existing under the laws of the United States (“Bank of America”),
in its capacity as administrative agent for the Lenders (as defined in the Credit Agreement (as
defined below)) (in such capacity, the “Administrative Agent”), and each of the Lenders signatory
hereto.

W I T N E S S E T H:

     WHEREAS, the Borrowers, the Administrative Agent and the Lenders have entered into that
certain Credit Agreement dated as of July 30, 2004 (as previously amended and as hereby amended and
as from time to time hereafter further amended, modified, supplemented, restated, or amended and
restated, the “Credit Agreement”; capitalized terms used in this Agreement not otherwise
defined herein shall have the respective meanings given thereto in the Credit Agreement), pursuant
to which the Lenders have made available to the Borrower a revolving credit facility, including a
letter of credit facility and a swing line facility; and

     WHEREAS, the Borrower has advised the Administrative Agent and the Lenders that it desires to
amend certain provisions of the Credit Agreement as set forth below and the Administrative Agent
and the Lenders signatory hereto are willing to effect such amendment on the terms and conditions
contained in this Agreement;

     NOW, THEREFORE, in consideration of the premises and further valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

     1. Amendments to Credit Agreement. Subject to the terms and conditions set forth
herein, the Credit Agreement is hereby amended as follows:

     (a) Section 2.14(a) of the Credit Agreement is hereby amended by deleting the
reference to “$50,000,000” in such section and replacing it with “$80,000,000” in lieu
thereof.

     (b) Section 6.11 of the Credit Agreement is hereby amended by deleting such
section in its entirety and replacing it with the following:

     6.11 Use of Proceeds. Use the proceeds of the Credit Extensions for
general corporate purposes not in contravention of any Law or of any Loan
Document; provided, however, that neither the Company nor any other
Borrower may use the proceeds of Credit Extensions to purchase or otherwise
acquire any shares of capital stock of the Company unless (i) such purchase
or acquisition is permitted by Section 7.07(c), (d) or
(f) and (ii) any shares of such capital stock of the
Company so acquired are retired or otherwise relegated to “unissued”
status immediately following the purchase or other acquisition thereof.

 

 

     (c) Section 6.02(b) of the Credit Agreement is hereby amended by deleting such
section in its entirety and replacing it with the following:

     (b) concurrently with the delivery of the financial statements
referred to in Sections 6.01(a) and (b), (i) a duly
completed Compliance Certificate signed by a Responsible Officer of the
Company, (ii) an updated Schedule 5.05 and an updated part (a) of
Schedule 5.13, showing all information required to be set forth in
each such Schedule, updated since the last delivery thereof, and (iii) in
the event that any one or more programs for the purchase or other
acquisition of Equity Interests issued by the Company was in effect as of
the date of such financial statements but had not at such time been fully
implemented, a certificate demonstrating Consolidated Net Worth as of the
date of such financial statements giving pro forma effect to the full
implementation of each such program then in effect (which may be included
as part of the Compliance Certificate required by part (i) of this
Section 6.02(b) above).

     (d) Section 7.07 of the Credit Agreement is hereby amended by (i) deleting the
word “and” at the end of subsection (d) thereof, (ii) deleting the period at the end of
subsection (e) thereof and replacing it with “; and”, and (iii) adding the following new
subsection (f) to Section 7.07:

     (f) the Company may make open market purchases or other acquisitions
of Equity Interests issued by it so long as (i) immediately after giving
effect to any such purchase or other acquisition, the Borrowers are in pro
forma compliance with each of the financial covenants set forth in
Section 7.12, and (ii) promptly following the adoption by the Board
of Directors (or other appropriate governing body) of the Company of any
program for such purchases or other acquisitions (and prior to making any
purchase or other acquisition pursuant to such a program), the Company
delivers to the Administrative Agent a certificate demonstrating pro forma
compliance with the Consolidated Net Worth covenant set forth in
Section 7.12(a) as of the date thereof and giving effect to all
repurchases or other acquisitions permitted under such program and any
other program then in effect.

     2. Effectiveness; Conditions Precedent. The effectiveness of this Agreement and the
amendments to the Credit Agreement herein provided are subject to the satisfaction of the following
conditions precedent, after which such satisfaction the amendments to the Credit Agreement herein
provided shall be deemed to be effective as of the Closing Date of the Credit Agreement:

2

 

     (a) the Administrative Agent shall have received each of the following documents or
instruments in form and substance reasonably acceptable to the Administrative Agent:

     (i) an original or facsimile (promptly followed by originals) executed
counterpart of this Agreement, duly executed by each Borrower, the Administrative
Agent and the Required Lenders;

     (ii) such other documents, instruments, certifications, undertakings, further
assurances and other matters as the Administrative Agent shall reasonably request;
and

     (iii) a certificate from a Responsible Officer of the Company demonstrating pro
forma compliance with the Consolidated Net Worth covenant set forth in Section
7.12(a) after giving effect to all purchases or other acquisitions of Equity
Interests of the Company authorized to be made pursuant to an approved program,
whether or not actually made, on or at any time after the Closing Date and through
the date of this Agreement; and

     (b) all fees and expenses payable to the Administrative Agent and the Lenders
(including the fees and expenses of counsel to the Administrative Agent) invoiced to date
shall have been paid in full.

     3. Consent and Continued Enforceability. Each Borrower hereby consents, acknowledges
and agrees to the amendments set forth herein and hereby confirms and ratifies in all respects its
obligations under the Credit Agreement and each other Loan Document (including without limitation
the continuation of such Borrower’s payment and performance obligations thereunder upon and after
the effectiveness of this Agreement and the amendments contemplated hereby) and the enforceability
of each such Loan Document against such Borrower in accordance with its terms.

     4. Representations and Warranties. In order to induce the Administrative Agent and
the Lenders to enter into this Agreement, each Borrower represents and warrants to the
Administrative Agent and the Lenders as follows:

     (a) The representations and warranties made by each Borrower in Article V of
the Credit Agreement and in each of the other Loan Documents to which such Borrower is a
party are true and correct on and as of the date hereof, except to the extent that such
representations and warranties expressly relate to an earlier date, and except that for
purposes of this Section 4, the representations and warranties contained in
subsections (a) and (b) of Section 5.05 of the Credit Agreement shall be deemed to
refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively,
of Section 6.01 of the Credit Agreement;

     (b) Other than the matters set forth on Schedule 5.06 of the Credit Agreement,
since the date of the Audited Financial Statements, there has been no event or circumstance,
either individually or in the aggregate, that has had or could reasonably be expected to
have a Material Adverse Effect;

3

 

     (c) The Persons appearing as Borrowers on the signature pages to this Agreement
constitute all Persons who are required to be Borrowers pursuant to the terms of the Credit
Agreement and the other Loan Documents, including without limitation all Persons who became
Material Subsidiaries or were otherwise required to become Borrowers after the Closing Date,
and each of such Persons has become and remains a party to the Credit Agreement as a
Borrower;

     (d) This Agreement has been duly authorized, executed and delivered by the Borrowers
party hereto and constitutes a legal, valid and binding obligation of such parties, except
as may be limited by general principles of equity or by the effect of any applicable
bankruptcy, insolvency, reorganization, moratorium or similar law affecting creditors’
rights generally; and

     (e) No Default or Event of Default has occurred and is continuing.

     5. Entire Agreement. This Agreement, together with all the Loan Documents
(collectively, the “Relevant Documents”), sets forth the entire understanding and agreement of the
parties hereto in relation to the subject matter hereof and supersedes any prior negotiations and
agreements among the parties relating to such subject matter. No promise, condition,
representation or warranty, express or implied, not set forth in the Relevant Documents shall bind
any party hereto, and no such party has relied on any such promise, condition, representation or
warranty. Each of the parties hereto acknowledges that, except as otherwise expressly stated in
the Relevant Documents, no representations, warranties or commitments, express or implied, have
been made by any party to the other. None of the terms or conditions of this Agreement may be
changed, modified, waived or canceled orally or otherwise, except in writing and in accordance with
Section 10.01 of the Credit Agreement.

     6. Full Force and Effect of Agreement. Except as hereby specifically amended,
modified or supplemented, the Credit Agreement and all other Loan Documents are hereby confirmed
and ratified in all respects and shall be and remain in full force and effect according to their
respective terms, with the amendments provided herein deemed to have been effective as of the
Closing Date of the Credit Agreement.

     7. Counterparts. This Agreement may be executed in any number of counterparts, each
of which shall be deemed an original as against any party whose signature appears thereon, and all
of which shall together constitute one and the same instrument. Delivery of an executed
counterpart of a signature page of this Agreement by telecopy shall be effective as delivery of a
manually executed counterpart of this Agreement.

     8. Governing Law. This Agreement shall in all respects be governed by, and construed
in accordance with, the laws of the State of New York applicable to contracts executed and to be
performed entirely within such State, and shall be further subject to the provisions of
Sections 10.14 and 10.15 of the Credit Agreement.

     9. Enforceability. Should any one or more of the provisions of this Agreement be
determined to be illegal or unenforceable as to one or more of the parties hereto, all other
provisions nevertheless shall remain effective and binding on the parties hereto.

4

 

     10. References. All references in any of the Loan Documents to the “Credit Agreement”
shall mean the Credit Agreement, as amended hereby.

     11. Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of the Borrower, the Administrative Agent and each of the Guarantors and Lenders, and their
respective successors, legal representatives, and assignees to the extent such assignees are
permitted assignees as provided in Section 10.04 of the Credit Agreement.

[Signature pages follow.]

5

 

     IN WITNESS WHEREOF, the parties hereto have caused this instrument to be made, executed and
delivered by their duly authorized officers as of the day and year first above written.

	 	 	 	 	 
	 	BORROWERS:

PEDIATRIX MEDICAL GROUP, INC., a 

Florida corporation

 	 
	 	By:  	/s/ Karl B. Wagner
 	 
	 	 	Name:  	Karl B. Wagner 	 
	 	 	Title:  	Chief Financial Officer 	 
	 

	 	 	 	 	 
	 	ALASKA NEONATOLOGY ASSOCIATES, INC.

ASSOCIATES IN NEONATOLOGY, INC.

AUGUSTA NEONATOLOGY ASSOCIATES, P.C.

BNA ACQUISITION COMPANY, INC.

CENTRAL OKLAHOMA NEONATOLOGY ASSOCIATES, INC.

CNA ACQUISITION CORP.

FLORIDA REGIONAL NEONATAL ASSOCIATES, INC.

FOOTHILL MEDICAL GROUP, INC.

FORT WORTH NEONATAL ASSOCIATES BILLING, INC.

GNPA ACQUISITION COMPANY, INC.

MAGELLA HEALTHCARE CORPORATION

MAGELLA HEALTHCARE GROUP, L.P.

MAGELLA MEDICAL ASSOCIATES BILLING, INC.

MAGELLA MEDICAL ASSOCIATES MIDWEST, P.C.

MAGELLA MEDICAL ASSOCIATES OF GEORGIA, P.C.

MAGELLA MEDICAL GROUP, INC.

MAGELLA NEVADA, LLC

MAGELLA TEXAS, LLC

 	 
	 	 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Karl B. Wagner
 	 
	 	 	Name:  	Karl B. Wagner 	 
	 	 	Title:  	Attorney-in-Fact 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

6

 

	 	 	 	 	 
	 	MNPC ACQUISITION COMPANY, INC.

MOUNTAIN STATES NEONATOLOGY, INC.

NACF ACQUISITION COMPANY, INC.

NEONATAL AND PEDIATRIC INTENSIVE CARE MEDICAL GROUP, INC.

NEONATOLOGY ASSOCIATES BILLING, INC.

NEONATAL SPECIALISTS, LTD.

NSPA ACQUISITION COMPANY, INC.

OBSTETRIX ACQUISITION COMPANY OF ARIZONA, INC.

OBSTETRIX ACQUISITION COMPANY OF COLORADO, INC.

OBSTETRIX MEDICAL GROUP OF ARIZONA, P.C.

OBSTETRIX MEDICAL GROUP OF CALIFORNIA, A PROFESSIONAL CORPORATION

OBSTETRIX MEDICAL GROUP OF COLORADO, P.C.

OBSTETRIX MEDICAL GROUP OF KANSAS AND MISSOURI, P.A.

OBSTETRIX MEDICAL GROUP OF PHOENIX, P.C.

OBSTETRIX MEDICAL GROUP OF TEXAS BILLING, INC.

OBSTETRIX MEDICAL GROUP OF WASHINGTON, INC., P.S.

OBSTETRIX MEDICAL GROUP, INC.

OZARK NEONATAL ASSOCIATES, INC.

PALM BEACH NEO ACQUISITIONS, INC.

PASCV ACQUISITION COMPANY, INC.

PEDIATRIX ACQUISITION COMPANY OF OHIO, INC.

PEDIATRIX ACQUISITION COMPANY OF WASHINGTON, INC.

PEDIATRIX FLORIDA LLC

 	 
	 	 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Karl B. Wagner
 	 
	 	 	Name:  	Karl B. Wagner 	 
	 	 	Title:  	Attorney-in-Fact 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

7

 

	 	 	 	 	 
	 	PEDIATRIX MEDICAL GROUP NEONATOLOGY AND PEDIATRIC INTENSIVE CARE SPECIALISTS OF

NEW YORK, P.C.

PEDIATRIX MEDICAL GROUP OF ARKANSAS, P.A.

PEDIATRIX MEDICAL GROUP OF CALIFORNIA, A PROFESSIONAL CORPORATION

PEDIATRIX MEDICAL GROUP OF COLORADO, P.C.

PEDIATRIX MEDICAL GROUP OF DELAWARE, INC.

PEDIATRIX MEDICAL GROUP OF FLORIDA, INC.

PEDIATRIX MEDICAL GROUP OF GEORGIA, P.C.

PEDIATRIX MEDICAL GROUP OF ILLINOIS, P.C.

PEDIATRIX MEDICAL GROUP OF INDIANA, P.C.

PEDIATRIX MEDICAL GROUP OF KANSAS, P.A.

PEDIATRIX MEDICAL GROUP OF KENTUCKY, P.S.C.

PEDIATRIX MEDICAL GROUP OF LOUISIANA, L.L.C.

PEDIATRIX MEDICAL GROUP OF MICHIGAN, P.C.

PEDIATRIX MEDICAL GROUP OF MISSOURI, P.C.

PEDIATRIX MEDICAL GROUP OF NEW MEXICO, P.C.

PEDIATRIX MEDICAL GROUP OF NORTH CAROLINA, P.C.

PEDIATRIX MEDICAL GROUP OF OHIO CORP.

PEDIATRIX MEDICAL GROUP OF OKLAHOMA, P.C.

 	 
	 	 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Karl B. Wagner
 	 
	 	 	Name:  	Karl B. Wagner 	 
	 	 	Title:  	Attorney-in-Fact 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

8

 

	 	 	 	 	 
	 	PEDIATRIX MEDICAL GROUP OF PENNSYLVANIA, P.C.

PEDIATRIX MEDICAL GROUP OF PUERTO RICO, P.S.C.

PEDIATRIX MEDICAL GROUP OF SOUTH CAROLINA, P.A.

PEDIATRIX MEDICAL GROUP OF TENNESSEE, P.C.

PEDIATRIX MEDICAL GROUP OF TEXAS BILLING, INC

PEDIATRIX MEDICAL GROUP OF WASHINGTON, INC., P.S.

PEDIATRIX MEDICAL GROUP, INC., a Utah corporation

PEDIATRIX MEDICAL GROUP, P.A.

PEDIATRIX MEDICAL GROUP, P.C., a Virginia corporation

PEDIATRIX MEDICAL GROUP, P.C., a West Virginia corporation

PEDIATRIX MEDICAL MANAGEMENT, L.P.

PEDIATRIX MEDICAL SERVICES, INC.

PEDIATRIX OF MARYLAND, P.A.

PEDIATRIX SCREENING, INC.

PEDIATRIX TEXAS I LLC

PEDIATRIX VIRGINIA ACQUISITION COMPANY, INC.

PERINATAL PEDIATRICS, P.A.

PMG ACQUISITION CORP.

PMGSC, P.A.

PNA ACQUISITION CO., INC.

POKROY MEDICAL GROUP OF NEVADA, LTD.

RPNA ACQUISITION COMPANY, INC.

SCPMC ACQUISITION CO.

SNCA ACQUISITION COMPANY, INC.

ST. JOSEPH NEONATOLOGY CONSULTANTS, INC.

 	 
	 	 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Karl B. Wagner
 	 
	 	 	Name:  	Karl B. Wagner 	 
	 	 	Title:  	Attorney-in-Fact 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

9

 

	 	 	 	 	 
	 	TEXAS MATERNAL FETAL MEDICINE BILLING, INC.

TEXAS NEWBORN SERVICES, INC.

TUCSON PERINATAL SERVICES, P.C.

 	 
	 	 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Karl B. Wagner
 	 
	 	 	Name:  	Karl B. Wagner 	 
	 	 	Title:  	Attorney-in-Fact 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

10

 

	 	 	 	 	 
	 	ADMINISTRATIVE AGENT:

BANK OF AMERICA, N.A.,

as Administrative Agent

 	 
	 	By:  	/s/ Kevin L. Ahart
 	 
	 	 	Name:  	Kevin L. Ahart 	 
	 	 	Title:  	Assistant Vice President 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

11

 

	 	 	 	 	 
	 	LENDERS:

BANK OF AMERICA, N.A. as a Lender, L/C Issuer and

Swing Line Lender

 	 
	 	By:  	/s/ Richard C. Hardison
 	 
	 	 	Name:  	Richard D. Hardison 	 
	 	 	Title:  	Vice President 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

12

 

	 	 	 	 	 
	 	HSBC BANK USA, NATIONAL ASSOCIATION

 	 
	 
	 	By:  	/s/ Steven C. Mayer
 	 
	 	 	Name:  	Steven C. Mayer 	 
	 	 	Title:  	Vice President 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

13

 

	 	 	 	 	 
	 	SUNTRUST BANK

 	 
	 	By:  	/s/ David P. Singleton
 	 
	 	 	Name:  	David P. Singleton 	 
	 	 	Title:  	Managing Director 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

14

 

	 	 	 	 	 
	 	U.S. BANK NATIONAL ASSOCIATION

 	 
	 	By:  	/s/ S. Walker Choppin
 	 
	 	 	Name:  	S. Walker Choppin 	 
	 	 	Title:  	Senior Vice President 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

15

 

	 	 	 	 	 
	 	WACHOVIA BANK, N.A.

 	 
	 	By:  	/s/ Juan C. Castro
 	 
	 	 	Name:  	Juan C. Castro 	 
	 	 	Title:  	Vice President 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

16

 

	 	 	 	 	 
	 	KEYBANK NATIONAL ASSOCIATION

 	 
	 	By:  	/s/
J.T. Taylor
 	 
	 	 	Name: 	J.T. Taylor	 
	 	 	Title:  	Senior Vice President 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

17

 

	 	 	 	 	 
	 	UBS LOAN FINANCE LLC

 	 
	 	By:  	/s/ Edward Cripps
 	 
	 	 	Name:  	Edward Cripps 	 
	 	 	Title:  	Director 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	                                              /s/ Joselin Fernandes
 	 
	 	 	Name:  	Joselin Fernandes 	 
	 	 	Title:  	Associate Director 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

18

 

	 	 	 	 	 
	 	THE INTERNATIONAL BANK OF MIAMI, N.A.

 	 
	 	By:  	/s/
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Pediatrix Medical Group, Inc.

Amendment No. 2 to Credit Agreement

Signature Pages

19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}]]